Price $40.38 |
Market Cap
228.25B
|
Sector Health Care |
Div. Growth
2.60%
|
|
P/E
7.5
|
P/B
2.41
|
P/S
2.3
|
Dividend %
4.00%
|
|
P/CF
-
|
P/FCF
13.8
|
Op. Cash Flow
29.27M
|
FCF
2.9
|
|
Op. Margin
36.40%
|
Net Margin
31.30%
|
ROE
35.10%
|
ROI
25.30%
|
|
ROA
16.30%
|
EPS Growth
42.60%
|
Current Ratio
1.2
|
Debt/Equity
34.40%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Invo Bioscience Inc (INVO) | $0.60 | - | - | 7.4M | Strong Buy |
| LifeVantage Corp (LFVN) | $3.51 | - | 3.10% | 48.7M | Strong Buy |
| PetIQ Inc (PETQ) | $11.23 | - | - | 315.7M | Strong Buy |
| Dare Bioscience Inc (DARE) | $1.06 | - | - | 95M | Strong Buy |
| Precision BioSciences Inc (DTIL) | $0.70 | - | - | 126.5M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
